reviewTop 1% cited
Alzheimer’s disease: experimental models and reality
Acta Neuropathologica · 2016 · Vol. 133(2) · pp. 155–175
Eleanor Drummond(Center for Neuro-Oncology)Thomas Wısnıewskı✉(Center for Neuro-Oncology)
Alzheimer's disease research and treatmentsNuclear Receptors and SignalingComputational Drug Discovery MethodsTangleDiseaseTransgeneNeuroscienceGenetically modified mouseAnimal modelPathologicalTranslation (biology)PathologyClinical trial
MeSH terms
Alzheimer DiseaseAnimalsDisease Models, AnimalHumansAnimals, Genetically Modified
Funding
- National Institutes of Health
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
Citations
787
FWCI
16.16
field-weighted impact
References
182
Percentile
99%
vs. same field & year
Citations per year
References
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Journal of Neuroscience · 2000 · 1,860 citations
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
Neuron · 2003 · 4,102 citations
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Neurology · 2002 · 3,414 citations
Primary age-related tauopathy (PART): a common pathology associated with human aging
Acta Neuropathologica · 2014 · 1,481 citations
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Neurobiology of Aging · 2003 · 997 citations
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Biological Psychiatry · 2014 · 1,338 citations
Neuropathological stageing of Alzheimer-related changes
Acta Neuropathologica · 1991 · 16,076 citations
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
Acta Neuropathologica · 2015 · 606 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.